These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2993410)

  • 1. The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis.
    Rigby WF; Noelle RJ; Krause K; Fanger MW
    J Immunol; 1985 Oct; 135(4):2279-86. PubMed ID: 2993410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of 1,25-dihydroxyvitamin D3 on T lymphocyte subpopulations.
    Rigby WF; Yirinec B; Oldershaw RL; Fanger MW
    Eur J Immunol; 1987 Apr; 17(4):563-6. PubMed ID: 3106071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphokine regulation of activated (G1) lymphocytes. II. Glucocorticoid and anti-Tac-induced inhibition of human T lymphocyte proliferation.
    Bettens F; Kristensen F; Walker C; Schwuléra U; Bonnard GD; de Weck AL
    J Immunol; 1984 Jan; 132(1):261-5. PubMed ID: 6606667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
    Chouaib S; Welte K; Mertelsmann R; Dupont B
    J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes.
    Kurki P; Lotz M; Ogata K; Tan EM
    J Immunol; 1987 Jun; 138(12):4114-20. PubMed ID: 2884260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cytokine, lymphocyte blastogenesis inhibitory factor (LBIF), arrests mitogen-stimulated T lymphocytes at early G1 phase with no influence on interleukin 2 production and interleukin 2 receptor light chain expression.
    Sugimura K; Ueda Y; Takeda K; Fukuda S; Tsukahara K; Habu Y; Fujiwara H; Azuma I
    Eur J Immunol; 1989 Aug; 19(8):1357-64. PubMed ID: 2673797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desferoxamine blocks IL 2 receptor expression on human T lymphocytes.
    Carotenuto P; Pontesilli O; Cambier JC; Hayward AR
    J Immunol; 1986 Apr; 136(7):2342-7. PubMed ID: 3005409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of interleukin 2 receptor expression: effects of phorbol diester, phospholipase C, and reexposure to lectin or antigen.
    Depper JM; Leonard WJ; Krönke M; Noguchi PD; Cunningham RE; Waldmann TA; Greene WC
    J Immunol; 1984 Dec; 133(6):3054-61. PubMed ID: 6092466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accessory cell requirement for activation antigen expression and cell cycle progression by human T lymphocytes.
    Williams JM; Ransil BJ; Shapiro HM; Strom TB
    J Immunol; 1984 Dec; 133(6):2986-95. PubMed ID: 6092462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol).
    Rigby WF; Stacy T; Fanger MW
    J Clin Invest; 1984 Oct; 74(4):1451-5. PubMed ID: 6332829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
    Tao X; Davis LS; Hashimoto K; Lipsky PE
    J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.
    Terada N; Lucas JJ; Szepesi A; Franklin RA; Domenico J; Gelfand EW
    J Cell Physiol; 1993 Jan; 154(1):7-15. PubMed ID: 8419408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3.
    Nunn JD; Katz DR; Barker S; Fraher LJ; Hewison M; Hendy GN; O'Riordan JL
    Immunology; 1986 Dec; 59(4):479-84. PubMed ID: 3026959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 1,25-dihydroxyvitamin D3 on the immunocompetent cells.
    Hoshino T; Iho S; Kura F
    Methods Find Exp Clin Pharmacol; 1986 Mar; 8(3):167-73. PubMed ID: 3487016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation.
    Bhalla AK; Amento EP; Serog B; Glimcher LH
    J Immunol; 1984 Oct; 133(4):1748-54. PubMed ID: 6206136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-Dihydroxyvitamin D3 modulates the effects of interleukin 2 independent of IL-2 receptor binding.
    Rigby WF; Hamilton BJ; Waugh MG
    Cell Immunol; 1990 Feb; 125(2):396-414. PubMed ID: 2105168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes.
    Davis L; Lipsky PE
    J Immunol; 1986 May; 136(10):3588-96. PubMed ID: 3486215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in activation markers and cell membrane receptors on human peripheral blood T lymphocytes during cell cycle progression after PHA stimulation.
    Poulton TA; Gallagher A; Potts RC; Beck JS
    Immunology; 1988 Jul; 64(3):419-25. PubMed ID: 3261709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-Dihydroxyvitamin D3 (calcitriol) suppresses IL-2 induced murine thymocyte proliferation.
    Haq AU
    Thymus; 1986; 8(5):295-306. PubMed ID: 3492067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-genomic immunosuppressive actions of progesterone inhibits PHA-induced alkalinization and activation in T cells.
    Chien EJ; Chang CP; Lee WF; Su TH; Wu CH
    J Cell Biochem; 2006 Sep; 99(1):292-304. PubMed ID: 16619256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.